Skip to content

Buyer

Pfizer takes 119 days to pay its suppliers.

Updated Nov 17, 2026Source: 10-K, filed Feb 26, 2026

Pfizer: $5.2B owed to suppliers at Dec 31, 2025, about 119 days to pay, from its own 10-K on SEC EDGAR.

Owes suppliers
$5.2B
Accounts payable at Dec 31, 2025, from its 10-K
Days to pay
119days
Year-end accounts payable over a full year of cost of goods
Among tracked buyers
18th slowest
of 154 buyers with days to pay

What Pfizer reports to the SEC

From the 10-K of PFIZER INC. Company-wide figures, each with its date.

SEC filer
PFIZER INCTicker PFE · CIK 78003
Accounts payable
$5.2B at Dec 31, 2025
Cost of goods
$16.1BJan 1, 2025 to Dec 31, 2025
Days to pay
119 daysYear-end accounts payable ÷ full-year cost of goods × 365
Fiscal year
FY2025, ended Dec 31, 2025

SEC EDGAR company facts, read by Kapwork on Nov 17, 2026. Company-wide figures: small suppliers often wait longer than the average. Terms to subcontractors aren't public.

What a vendor to Pfizer should know

Each tile reads one public record against a fixed rule. The status is Kapwork's reading of public data, not a credit opinion.

Trend in days to pay
+4 days
No concern foundChange from FY2024 to FY2025.FY2021 to FY2025: 66, 72, 98, 115 and 119 days.
The ruleA rise of less than 5 days in a year reads "No concern found". 5 days or more reads "Worth a look". 20 days or more reads "Check first".
Against peers
+51 days
Check firstSlower than the median of 18 Pharmaceuticals, Biotechnology & Life Sciences companies (68 days).
The ruleAt most 5 days slower than the peer median reads "No concern found". Up to 30 days slower reads "Worth a look". More than 30 days slower reads "Check first".
Can it pay?
4.1x
No concern foundCash and short-term investments against debt due in 12 months.Cash $1.8B and short-term investments $9.1B. Debt due in 12 months $2.7B. Quarter ended Sep 27, 2026.Unused credit lines are not in the tagged filing data, so the ratio can read low.
The rule1.5x or more reads "No concern found". 0.5x to 1.5x reads "Worth a look". Less than 0.5x reads "Check first". Debt service coverage below 1.0x, or cash flow that covers less than half of the payables, holds the tile at "Worth a look".
Warning signs
None
No concern foundNo warning filings in 24 months.Going-concern language in the annual report is not checked.
The ruleNo warning filing in 24 months reads "No concern found". One filing reads "Worth a look". A default, going-concern doubt or two filings read "Check first". A distress-zone result of the standard distress model holds the tile at "Worth a look".
Distress models
Watch zone
Worth a lookAltman Z-Score 1.95. Ohlson O-Score: 4.7% modeled chance of failure, elevated.Not a credit rating. Kapwork does not rate companies.
The ruleStable zone reads "No concern found". Watch zone reads "Worth a look". Stressed zone reads "Check first". The zone is that of the Altman model that fits the company: the original for manufacturers, the revised one for others. The O-Score is shown, not scored.
Early-pay program
$523M
Worth a lookAvailable. 13% of accounts payable. Down 8% in a year.The filing does not say which balance sheet line holds the program. We assume the payables line it tags.
The ruleA program of less than 5% of payables reads "No concern found". 5% to 20% reads "Worth a look". More than 20% reads "Check first".

Sources: SEC EDGAR, Nov 15, 2026. Distress models use public formulas (Altman 1968 and 1995, Ohlson 1980).

What changed

Leadership changes and warning filings from SEC filings, last 12 months, newest first.

Nov 3, 2026Leadership
From the filing: "On November 3, 2026, Pfizer Inc. (the "Company") announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the "Effective ..." Form 8-K, item 5.02
Jun 18, 2026Leadership
From the filing: "On June 16, 2026, Dave Denton notified Pfizer Inc. (the "Company") that he will step down from his current position as Chief Financial Officer effective August 15, 2026 for a professional opportunity outside of the pharmaceutical industry in consumer ..." Form 8-K, item 5.02

Sources: SEC EDGAR, Nov 15, 2026.

All 202 buyers · Fastest to slowest payer

Already invoice Pfizer?

Certify your approved invoices. Funders compete to fund them.

  • Multiple offers
  • No notice of assignment from Kapwork
  • Free for businesses

$700M+ certified. SOC 2 Type I & II.